Benralizumab treatment in an elderly patient with eosinophilic esophagitis resulted in remission: a case report

Benralizumab treatment in an elderly patient with eosinophilic esophagitis resulted in remission: a case report

Abstract Background Interleukin-5 (IL-5) has recently been shown to play a crucial role in eosinophil-mediated diseases, implying that an IL-5 receptor alpha chain (IL-5Rα) antibody (benralizumab) can be effective against eosinophilic esophagitis (EoE). Here, we present a case in which benralizumab...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Azusa Ishii, Tomofumi Shibata, Yohei Tsunoda, Takafumi Kayukawa, Masahiro Kobayashi, Masami Orinaka, Shoko Miyamatsu, Yoshio Ryuge, Shuichi Asano, Ichidai Tanaka
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: BMC 2024-01-01
Ráidu:BMC Geriatrics
Fáttát:
Eosinophilic esophagitis
Interleukin-5 receptor alpha chain antibody
Benralizumab
Elderly patient
Liŋkkat:https://doi.org/10.1186/s12877-024-04683-1

Interneahtta

https://doi.org/10.1186/s12877-024-04683-1

Geahča maid